Connexa Sports (YYAI) 10-K 24 Aug 20 2020 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Apr. 30, 2020	Aug. 24, 2020	Oct. 31, 2019
Cover [Abstract]
Entity Registrant Name	Slinger Bag Inc.
Entity Central Index Key	0001674440
Document Type	10-K
Document Period End Date	Apr. 30, 2020
Amendment Flag	false
Current Fiscal Year End Date	--04-30
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filer	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 8,760,000
Entity Common Stock, Shares Outstanding		26,209,714
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Apr. 30, 2020	Apr. 30, 2019
Current assets
Cash	$ 79,847	$ 1,994
Inventory	919,644
Prepaid expenses and other current assets	381,510	645
Total current assets	1,381,001	2,639
Property and equipment, net		750
Intangible assets, net		1,734
Total assets	1,381,001	5,123
Current liabilities
Accounts payable and accrued expenses	989,112
Deferred revenue	179,366
Accrued interest - related parties	138,967
Stock refund payable		1,200
Notes payable - related party	2,100,000
Convertible notes payable, net	82,128
Derivative liability	620,238
Due to related parties	377,106	10,114
Total current liabilities	4,486,917	11,314
Long-term liabilities
Long-term portion of convertible notes payable, net	1,493,939
Note payable, net	393,975
Total liabilities	6,374,831	11,314
Commitments and contingencies
Stockholders' deficit
Common stock, $0.001 par value, 300,000,000 shares authorized, 24,749,354 and 24,380,000 shares issued and outstanding as of April 30, 2020 and 2019, respectively; 8,137,859 shares issuable as of April 30, 2020	24,749	24,380
Additional paid-in capital	5,214,970	2,520
Accumulated other comprehensive loss	(5,036)
Accumulated deficit	(10,228,513)	(33,091)
Total stockholders' deficit	(4,993,830)	(6,191)
Total liabilities and stockholders' deficit	$ 1,381,001	$ 5,123

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Apr. 30, 2020	Mar. 02, 2020	Feb. 25, 2020	Feb. 24, 2020	Apr. 30, 2019
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001				$ 0.001
Common stock, shares authorized	300,000,000		300,000,000	75,000,000	300,000,000
Common stock, shares issued	24,749,354	369,354			24,380,000
Common stock, shares outstanding	24,749,354				24,380,000
Shares issuable	8,137,859

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Income Statement [Abstract]
Net sales	$ 686,179
Cost of sales	1,370,897
Gross loss	(684,718)
Operating expenses:
Selling and marketing expenses	563,003
General and administrative expenses	1,549,329	28,289
Stock-based compensation	3,741,746
Research and development costs	179,982
Transaction costs	198,443
Total operating expenses	6,232,503	28,289
Loss from operations	(6,917,221)	(28,289)
Other expenses:
Amortization of debt discount	1,565,174
Interest expense - related party	171,918
Interest expense	573,431
Total other expense	2,310,523
Loss before income taxes	(9,227,744)	(28,289)
Provision for (benefit from) income taxes
Net loss	(9,227,744)	(28,289)
Other comprehensive loss, net of tax
Foreign currency translation adjustments	(5,034)
Total other comprehensive loss, net of tax	(5,034)
Comprehensive loss	$ (9,232,778)	$ (28,289)
Net loss per share, basic and diluted	$ (0.37)	$ 0
Weighted average number of common shares outstanding, basic and diluted	24,689,813	24,393,808

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income [Member]	Accumulated Deficit [Member]	Total
Balance at Apr. 30, 2018	$ 24,260	$ 3,480		$ (4,802)	$ 23,298
Balance, shares at Apr. 30, 2018	24,620,000
Forgiveness of net liabilities owed to former majority shareholder
Foreign currency translation
Common shares cancelled	$ (240)	(960)			(1,200)
Common shares cancelled, shares	(240,000)
Net loss				(28,289)	(28,289)
Balance at Apr. 30, 2019	$ 24,380	2,520		(33,091)	(6,191)
Balance, shares at Apr. 30, 2019	24,380,000
Contribution of Slinger Bag Limited			(2)	(967,678)	(967,680)
Shares issuable related to note payable		1,492,188			1,492,188
Distribution to shareholder		(332,239)			(332,239)
Forgiveness of net liabilities owed to former majority shareholder		15,289			15,289
Share issued for conversion of convertible debt	$ 369	182,476			182,845
Share issued for conversion of convertible debt, shares	369,354
Stock-based compensation		3,741,746			3,741,746
Warrants issued with note payable		112,990			112,990
Foreign currency translation			(5,034)		(5,034)
Net loss				(9,227,744)	(9,227,744)
Balance at Apr. 30, 2020	$ 24,749	$ 5,214,970	$ (5,036)	$ (10,228,513)	$ (4,993,830)
Balance, shares at Apr. 30, 2020	24,749,354

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Cash flows from operating activities
Net loss	$ (9,227,744)	$ (28,289)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	650	2,600
Stock-based compensation	3,741,746
Non-cash interest expense	358,855
Amortization of debt discount	1,565,174
Changes in operating assets and liabilities:
Inventory	(919,644)
Prepaid expenses and other current assets	(381,510)
Accounts payable and accrued expenses	855,853	(2,099)
Deferred revenue	(706,408)
Accrued interest - related parties	138,967
Due to related parties	365,787
Net cash used in operating activities	(4,208,274)	(27,788)
Cash flows from investing activities
Proceeds from contribution of net assets of Slinger Bag Limited	73,400
Net cash provided by investing activities	73,400
Cash flows from financing activities
Distribution to shareholder	(332,239)
Proceeds from notes payable - related party	2,100,000	9,000
Proceeds from note payable	500,000
Proceeds from convertible note payable	1,950,000
Net cash provided by financing activities	4,217,761	9,000
Effect of exchange rate fluctuations on cash	(5,034)
Net change in cash	77,853	(18,788)
Cash, beginning of the period	1,994	20,782
Cash, end of the period	79,847	1,994
Supplemental disclosure of cash flow information:
Interest paid	224,726
Income taxes paid
Supplemental disclosure of non-cash investing and financing information:
Forgiveness of net liabilities owed to former majority shareholder	15,289
Shares issuable related to convertible note payable agreement	1,492,188
Debt discount due to derivative liability	673,809
Conversion of note payable and accrued interest into common stock	182,845
Warrants issued with note payable	112,990
Net assets contributed from Slinger Bag Limited	(967,680)
Cancellation of common stock for refund payable		$ 1,200

Organization and Basis of Prese

Organization and Basis of Presentation	12 Months Ended
	Apr. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Basis of Presentation	NOTE 1: ORGANIZATION AND BASIS OF PRESENTATION Organization Lazex Inc. (“Lazex”) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (“Slinger Bag Americas”) which was 100% owned by Slinger Bag Ltd. (“SBL”), an Israeli company. In connection with the Stock Purchase Agreement, Slinger Bag Americas acquired 20,000,000 shares of common stock of Lazex for $332,239. On September 16, 2019, SBL transferred its ownership of Slinger Bag Americas to Lazex in exchange for the 20,000,000 shares of Lazex acquired on August 23, 2019. As a result of these transactions, Lazex owned 100% of Slinger Bag Americas and the sole shareholder of SBL now owned 20,000,000 shares of common stock (approximately 82%) of Lazex. Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc. On October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (“Slinger Bag Canada”) a Canadian company incorporated on November 3, 2017. There are no assets or liabilities or historical operational activity of Slinger Bag Canada. On February 10, 2020, Slinger Bag Americas became the 100% owner of SBL, along with SBL’s wholly owned subsidiary Slinger Bag International (UK) Limited (“Slinger Bag UK”) formed on April 3, 2019, after Zehava Tepler, the owner of SBL, contributed it to Slinger Bag Americas for no consideration. The operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK and SBL are collectively referred to as the “Company.” The Company operates in the sporting and athletic goods business. The Company is the owner of Slinger Launcher, which is a portable tennis ball launcher. Effective February 25, 2020, the Company increased its number of authorized shares of common stock from 75,000,000 to 300,000,000 and effected a four-to-one forward split of the outstanding shares of common stock. All share and per share information contained in this report have been retroactively adjusted to reflect the impact of the stock split. Basis of Presentation The accompanying consolidated financial statements of the Company are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). As a result of the transactions described above, the accompanying consolidated financial statements include the combined results of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK and SBL for the year ended April 30, 2020. The contribution of the net assets of SBL is reflected as an equity contribution at historical cost on May 1, 2019, the beginning of the earliest period in which the entities were under common control. There was no historical activity in Slinger Bag Americas or Slinger Bag Canada prior to May 1, 2019. The accompanying financial statements for the year ended April 30, 2019 reflect the historical results of Slinger Bag Inc. (formerly known as Lazex). All intercompany accounts and transactions have been eliminated in consolidation.

Going Concern

Going Concern	12 Months Ended
	Apr. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 2: GOING CONCERN The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has an accumulated deficit of $10,228,513 as of April 30, 2020 and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or being able to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they become due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related parties, and/or private placement of common stock.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Apr. 30, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Accordingly, actual results could differ from those estimates. Financial Statement Reclassification Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications. Cash and Cash Equivalents The Company considers all highly liquid temporary cash investments with an original maturity of three months or less when purchased, to be cash equivalents. Inventory Inventory is valued at the lower of the cost or net realizable value. The Company’s inventory as of April 30, 2020 consisted of $663,750 of finished goods and $255,894 of component and replacement parts. The Company had no inventory at April 30, 2019. Concentration of Credit Risk The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash or cash equivalents. Revenue Recognition Effective May 1, 2018, the Company adopted Accounting Standards Codification (“ASC”) 606, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services. The adoption of ASC 606 had no impact on the Company’s historical financial statements. The Company’s contracts with customers contain one performance obligation. The Company recognizes revenue for its performance obligation at a point in time once products are shipped or physically delivered, depending on the third-party shipping terms. Amounts collected from customers in advance of revenue being recognized are reflected as deferred revenue on the accompanying consolidated balance sheets. Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in the absence of a principal, most advantageous market for the specific asset or liability. GAAP provides for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows: ● Level 1 — Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access. ● Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including: – Quoted prices for similar assets or liabilities in active markets – Quoted prices for identical or similar assets or liabilities in markets that are not active – Inputs other than quoted prices that are observable for the asset or liability – Inputs that are derived principally from or corroborated by observable market data by correlation or other means ● Level 3 — Inputs that are unobservable and reflect the Company’s own assumptions about the assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows). The Company’s financial instruments consist of cash and cash equivalents, accounts payable and amounts due to related parties. The carrying amount of these financial instruments approximates fair value due to their short-term maturity. The Company’s derivative liability was calculated using Level 2 assumptions. Income Taxes Income taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts expected to be realized, but no less than quarterly. Property and Equipment Property and equipment are recorded at cost and are depreciated on a straight-line basis over their estimated useful lives of three years. At April 30, 2019, the Company had total capitalized property and equipment costs of $3,000 and accumulated depreciation of $2,250. In connection with the Stock Purchase Agreement (see Note 1), the existing property and equipment with a remaining book value of $500 was contributed to the previous majority shareholder of Lazex. As of April 30, 2020, the remaining book value of property and equipment were $0. Depreciation expense for the year ended April 30, 2020 and 2019 was $250 and $1,000, respectively. Intangible Assets Intangible assets consisted of capitalized software costs and are amortized on a straight-line basis over an estimated useful life of three years. At April 30, 2019, the Company had total gross intangible assets of $4,800 and accumulated amortization of $3,066. In connection with the Stock Purchase Agreement (see Note 1), the existing capitalized software with a remaining book value of $1,334 was contributed to the previous majority shareholder of Lazex. As of April 30, 2020, the remaining book value of intangible assets were $0. Amortization expense for the year ended April 30, 2020 and 2019 was $400 and $1,600, respectively. Long-Lived Assets In accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. Impairment, if any, is based on the excess of the carrying amount over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. There was no impairment of long-lived assets identified during the year ended April 30, 2020 or 2019. Warrants The Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in connection with certain note payable agreements. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants granted in connection with ongoing arrangements are more fully described in Note 6: Note Payable and Note 8: Stockholders’ Deficit. The warrants granted during the year ended April 30, 2020 and 2019 were valued using the Black-Scholes pricing method on the date of grant using the following assumptions below. 2020 2019 Expected life in years 2 - 5 years NA Stock price volatility 121.4% - 144.2% NA Risk free interest rate 0.36% - 2.43% NA Expected dividends 0% NA Basic and Diluted Earnings Per Share Basic earnings per share are calculated by dividing income available to stockholders by the weighted-average number of common shares outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common share equivalents outstanding during the period. The Company had 8,137,859 common shares issuable as of April 30, 2020 (see Note 5) which were not included in the calculation of diluted earnings per share as the effect is antidilutive. The Company also had outstanding notes payable convertible into 7,465,811 shares of common stock as of April 30, 2020 (see Note 5), as well as outstanding warrants exercisable into 13,000,000 shares of common stock which were excluded from calculation of diluted earnings per share as the effect is antidilutive. There were no common share equivalents outstanding during the year ended April 30, 2019. As a result, the basic and diluted earnings per share are the same for each of the periods presented. Recent Accounting Pronouncements In February 2016, the FASB issued Accounting Standards Update 2016-02, “Leases” (Topic 842). This guidance is effective for public entities for fiscal years beginning after December 15, 2018 including the interim periods within those fiscal years. Early application is permitted. Under the new provisions, all lessees will report a right-of-use asset and a liability for the obligation to make payments for all leases with the exception of those leases with a term of 12 months or less. All other leases will fall into one of two categories: (i) Financing leases, similar to capital leases, which will require the recognition of an asset and liability, measured at the present value of the lease payments and (ii) Operating leases which will require the recognition of an asset and liability measured at the present value of the lease payments. The Company has adopted this standard on May 1, 2019 with no significant impact to the Company’s financial statements. Other accounting pronouncements have been issued but deemed by management to be outside the scope of relevance to the Company.

Note Payable - Related Party

Note Payable - Related Party	12 Months Ended
	Apr. 30, 2020
Debt Disclosure [Abstract]
Note Payable - Related Party	NOTE 4: NOTE PAYABLE – RELATED PARTY On October 3, 2019, the Company entered into a loan agreement with a related party entity controlled by the former shareholder of Slinger Bag Canada for borrowings of $500,000 bearing interest at 12% per annum. All principal and accrued interest were due on demand under the original agreement. On December 13, 2019, the Company entered into an Amended and Restated Loan Agreement making the all principal and accrued interest due on July 15, 2020. On July 8, 2020, the terms of the debt were amended to extend the due date to January 8, 2021 (see Note 11). On December 3, 2019, the Company entered into a loan agreement with the same related party for borrowings of $500,000 bearing interest at 12% per annum. All principal and accrued interest were due on demand under the original agreement. On December 13, 2019, the Company entered into an Amended and Restated Loan Agreement increasing the interest rate earned from 12% to 24% per annum and making the all principal and accrued interest due on July 15, 2020. On July 8, 2020, the terms of the debt were amended to extend the due date to January 8, 2021 (see Note 11). On December 11, 2019, the Company entered into a loan agreement with the same related party for borrowings of $700,000 bearing interest at 24% per annum. All principal and accrued interest were due on July 15, 2020. On July 8, 2020, the terms of the debt were amended to extend the due date to January 8, 2021 (see Note 11). On January 6, 2019, the Company entered into a loan agreement with the same related party for borrowings of $200,000 bearing interest at 24% per annum. All principal and accrued interest were due on January 8, 2021. On July 8, 2020, the terms of the debt were amended to extend the due date to January 8, 2021 (see Note 11). On March 1, 2020, the Company entered into a loan agreement with the same related party for borrowings of $200,000 bearing interest at 24% per annum. All outstanding borrowings and accrued interest under all agreements are due on January 8, 2021. The Company received additional borrowings totaling $1.75 million from this related party subsequent to the year end April 30, 2020 (see Note 11). Interest expense related to this related party for the year ended April 30, 2020 and 2019 amounted to $171,918 and $0, respectively. Accrued interest due to the related party amounted to $138,967 as of April 30, 2020.

Convertible Notes Payable

Convertible Notes Payable	12 Months Ended
	Apr. 30, 2020
Debt Disclosure [Abstract]
Convertible Notes Payable	NOTE 5: CONVERTIBLE NOTES PAYABLE On June 1, 2019, the Company entered into a note payable agreement with Montsaic Investments (“Montsaic”) which provided for borrowings of $1,700,000 bearing interest at a rate of 12.6% per annum. All outstanding amounts are due on the maturity date 360 days after the loan issue date. The Company may repay up to 50% of the outstanding balance on the loan prior to the maturity date at their discretion. The outstanding principal and accrued interest are convertible into shares of the Company’s common stock at any time at the option of the debtholder at a conversion price equal to 75% of the lowest closing price of the common stock as defined in the agreement. Effective June 1, 2020, the Company and Montsaic entered into an amendment to the note payable agreement to eliminate the conversion right contained in the original agreement and extend the maturity date to June 1, 2021 (see Note 11). The note payable agreement, as amended on September 11, 2019, also provides Montsaic with a warrant giving them the right to acquire 33% of the outstanding shares of SBL on a fully-diluted basis for no consideration up through the maturity date. On September 16, 2019, Montsaic and Slinger Bag Inc. entered into a warrant assignment and conveyance agreement which transferred the right to acquire 33% of the outstanding common stock shares of SBL to Slinger Bag Inc. The allocated value of the warrant amounted to $1,492,188, which has been reflected as a discount to the outstanding note balance. The Company has not issued the shares of common stock as of April 30, 2020. As a result, as of April 30, 2020 the Company has 8,137,859 shares of common stock that are issuable. On May 6, 2020, the Company issued 1,216,560 shares of common stock as partial satisfaction of the shares issuable (see Note 11). The Company evaluated the conversion option under the guidance in ASC 815-10, Derivatives and Hedging, and determined it to have characteristics of a derivative liability. Under this guidance, this derivative liability is marked-to-market at each reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivatives. The value of the conversion option amounted to $566,667 as of the issuance date on September 11, 2019, which has been recorded as a discount to the outstanding note balance, less $358,855 representing the amount of the conversion option exceeding the face value of the note payable which was recorded immediately as interest expense, and a derivative liability. There was no change in the derivative liability as of April 30, 2020. The combined discount relating to the warrant and conversion option are being amortized over the term of the agreement. Amortization of debt discounts during the year ended April 30, 2020 amounted to $1,493,939, and is recorded as amortization of debt discount in the accompanying consolidated statements of operations. The unamortized discount balance amounted to $206,061 as of April 30, 2020. On November 20, 2019, the Company entered into a convertible note payable agreement for borrowings of $125,000 bearing interest at 12% per annum. All outstanding borrowings and accrued interest are due on November 20, 2020. The outstanding principal and accrued interest are convertible into shares of the Company’s common stock at any time at the option of the debtholder at a conversion price equal to 70% of the lowest closing price of the common stock as defined in the agreement. On March 2, 2020, the holder elected to convert the outstanding principal of $125,000 and accrued interest of $4,274 into 369,354 shares of the Company’s common stock in accordance with the terms in the agreement. The remaining balance outstanding was $0 at April 30, 2020. The Company evaluated the conversion option under the guidance in ASC 815-10, Derivatives and Hedging, and determined it to have characteristics of a derivative liability. Under this guidance, this derivative liability is marked-to-market at each reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivatives. The value of the conversion option amounted to $53,571 as of the issuance date on November 20, 2019, which was initially recorded as a discount to the outstanding note balance and a derivative liability. The discount of $53,571 was fully amortized during the year ended April 30, 2020 upon the conversion of the outstanding note payable balance. Upon conversion of the note payable balance, the derivative liability amount of $53,571 was reclassified as additional paid-in capital as part of stockholders’ equity. On February 11, 2020, the Company entered into a convertible note payable agreement for borrowings of $125,000 bearing interest at 12% per annum. All outstanding borrowings and accrued interest are due on February 11, 2021. The outstanding principal and accrued interest are convertible into shares of the Company’s common stock at any time at the option of the debtholder at a conversion price equal to 70% of the lowest closing price of the common stock as defined in the agreement. The Company evaluated the conversion option under the guidance in ASC 815-10, Derivatives and Hedging, and determined it to have characteristics of a derivative liability. Under this guidance, this derivative liability is marked-to-market at each reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivatives. The value of the conversion option amounted to $53,571 as of the issuance date on February 11, 2020, which was initially recorded as a discount to the outstanding note balance and a derivative liability. There was no change in the fair value of the derivative liability as of April 30, 2020. The discount is being amortized over the term of the agreement. Amortization of debt discounts during the year ended April 30, 2020 amounted to $10,699 and is recorded as amortization of debt discount in the accompanying consolidated statements of operations. The unamortized discount balance amounted to $42,872 as of April 30, 2020. Total outstanding principal of convertible notes payable at April 30, 2020 and 2019 amounted to $1,825,000 and $0, respectively. The outstanding balances are netted with debt discounts at April 30, 2020 and 2019 of $248,933 and $0, respectively. Future scheduled maturities of long-term convertible debt are as follows. Year Ended April 30, 2021 $ 125,000 2022 1,700,000 Total $ 1,825,000

Note Payable

Note Payable	12 Months Ended
	Apr. 30, 2020
Notes to Financial Statements
Note Payable	NOTE 6: NOTE PAYABLE On March 16, 2020, the Company entered into a promissory note payable whereby the Company borrowed $500,000 bearing interest at 12% per annum. Interest on the note is payable monthly and outstanding principal on the note is due in full on March 16, 2022. Future scheduled maturities of long-term debt are as follows. Year Ended April 30, 2021 $ - 2022 500,000 Total $ 500,000 In connection with the promissory note payable on March 16, 2020, the Company issued warrants to purchase 500,000 shares of the Company’s common stock at an exercise price equal to a 40% discount of the market price of the Company’s stock, as defined in the agreement. The warrants expire on March 16, 2022 and are fully vested upon issuance. The note was discounted by $112,990 allocated from the valuation of the warrants issued. The discount recorded on the note is being amortized as interest expense through the maturity date, which amounted to $6,965 for year ended April 30, 2020. As of April 30, 2020, the net book value of the promissory note amounted to $393,975 including the principal amount outstanding of $500,000 net of the remaining discount of $106,025.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Apr. 30, 2020
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 7: RELATED PARTY TRANSACTIONS In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attain adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by officers, directors, or shareholders. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are considered temporary in nature and have not been formalized by a promissory note. As of April 30, 2019, the Company had $10,114 of outstanding borrowings from the previous majority shareholder and sole officer and director of the Company. The borrowings were non-interest bearing and due on demand. In connection with the Stock Purchase Agreement (see Note 1), the outstanding balances were forgiven. As of April 30, 2020, amounts due to related parties were $377,106 which represented unpaid salaries and reimbursable expenses due to officers of the Company. The Company has outstanding notes payable of $2,100,000 and accrued interest of $138,967 due to a related party as of April 30, 2020 (see Note 4).

Stockholders' Deficit

Stockholders' Deficit	12 Months Ended
	Apr. 30, 2020
Stockholders' Equity Note [Abstract]
Stockholders' Deficit	NOTE 8: STOCKHOLDERS’ DEFICIT Common Stock The Company has 300,000,000 shares of common stock authorized with a par value of $0.001 per share. As of April 30, 2020, the Company had 24,749,354 shares of common stock issued and outstanding. Equity Transactions During Year Ended April 30, 2019 On May 15, 2018, the Company cancelled 240,000 of its common shares and accrued a stock refund payable of $1,200 as of April 30, 2019. Equity Transactions During Year Ended April 30, 2020 On March 2, 2020, the Company issued 369,354 shares of common stock for the conversion of outstanding convertible notes payable of $125,000 and accrued interest of $4,274. Upon conversion of the note payable balance, the derivative liability amount of $53,571 was reclassified as additional paid-in capital as part of stockholders’ equity. The purchase price of $332,239 under the Stock Purchase Agreement (see Note 1) which resulted in shares of Lazex being acquired by the shareholder of SBL, was paid by SBL on behalf of the shareholder. The amount has been recorded as a distribution to shareholder and therefore is classified as a reduction of additional paid-in capital. In connection with the Stock Purchase Agreement (see Note 1), net liabilities of $15,289 were forgiven by the previous majority shareholder of the Company which was recorded as an increase to additional paid-in capital. On March 16, 2020, the Company issued warrants valued at $112,990 in connection with a note payable (see Note 6) which increased additional paid-in capital. Common Stock Issuable As discussed in Note 5, on September 16, 2019, the Company entered into a warrant assignment and conveyance agreement with Montsaic, pursuant to which the Company allows Montsaic to acquire 33% of the outstanding common stock shares of the Company on a fully-diluted basis for no consideration. The allocated value of the warrant amounted to $1,492,188, which has been reflected as additional paid-in capital. There are 8,137,859 shares of common stock that are issuable under this agreement. As of April 30, 2020, none of these shares have been issued. Warrants Issued for Compensation On April 30, 2020, the Company granted an aggregate total of 12,500,000 warrants to key employees and officers of the Company as compensation. The warrants have an exercise price of $0.001 per share, a contractual life of 10 years from the date of issuance, and are vested immediately upon grant. The warrants granted as compensation during the year ended April 30, 2020 were valued using the Black-Scholes pricing method. The total stock-based compensation expense related to the issuance of the warrants amounted to $3,741,746.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Apr. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 9: COMMITMENTS AND CONTINGENCIES Leases The Company leases its office space under short-term leases with terms under a year. Total rent expense for the year ended April 30, 2020 and 2019 amounted to $2,800 and $0, respectively. Contingencies From time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company is not presently a party to any legal proceedings that it currently believes would individually or taken together have a material adverse effect on the Company’s business or financial statements.

Income Taxes

Income Taxes	12 Months Ended
	Apr. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 10: INCOME TAXES The Company does business in the US through its subsidiaries Slinger Bag Inc. and Slinger Bag Americas. It also does business in Israel through SBL, whose operations are reflected in the Company’s consolidated financial statements from May 1, 2019 on, the beginning of the earliest period in which the entities were under common control. Net deferred tax assets from operations in the US, using an effective tax rate of 21%, consisted of the following. April 30, April 30, 2020 2019 Deferred tax assets (liabilities): Loss carryforwards $ 301,000 $ 9,500 Depreciation - (400 ) Related party accruals 79,000 - Start-up costs 61,000 - Valuation allowance (441,000 ) (9,100 ) Net deferred tax assets $ - $ - The income tax provision differs from the amount of income tax determined by applying the applicable US statutory income tax rate of 21% to pretax loss due to the following for the year ended April 30, 2020 and 2019. April 30, April 30, 2020 2019 Income tax benefit based on book loss at US statutory rate $ (1,273,000 ) $ (5,900 ) Stock-based compensation 786,000 - Debt discount amortization 15,000 - Related party accruals 79,000 - Start up costs 61,000 - Interest expense 41,000 - Meals and entertainment 1,000 - Depreciation - 400 Valuation allowance 290,000 5,500 Total income tax provision $ - $ - The Company had net operating loss carryforwards of approximately $1,424,000 as of April 30, 2020 which can be used to offset future taxable income in the US from the year 2021 through 2040. Tax years that remain subject to examination are 2017 and forward. Net deferred tax assets from operations in Israel , using an effective tax rate of 23%, consisted of the following. The net deferred tax assets as of April 30, 2019 represent the amounts from SBL contributed to the Company on May 1, 2019. April 30, April 30, 2020 2019 Deferred tax assets (liabilities): Loss carryforwards $ 384,000 $ 201,000 Accrued expenses 63,000 16,000 Research and development costs 23,000 - Valuation allowance (470,000 ) (216,000 ) Net deferred tax assets $ - $ - The income tax provision differs from the amount of income tax determined by applying the applicable Israeli statutory income tax rate of 23% to pretax loss due to the following for the year ended April 30, 2020. As the net assets of SBL were contributed on May 1, 2019, there is no income tax provision related to the year ended April 30, 2019. April 30, 2020 Income tax benefit based on book loss at Israeli statutory rate $ (728,000 ) Debt discount amortization 430,000 Related party accruals 44,000 Travel 38,000 Research and development 23,000 Other non-deductible items 9,000 Valuation allowance 184,000 Total income tax provision $ - The Company had net operating loss carryforwards of approximately $1,671,000 as of April 30, 2020 which can be used to offset future taxable income in Israel. All of the Company’s tax years since inception are open for examination. The Company’s policy is to record interest and penalties on uncertain tax positions as income tax expense. There were no interest or penalties recognized in the accompanying consolidated statements of operations for the year ended April 30, 2020 or 2019.

Subsequent Events

Subsequent Events	12 Months Ended
	Apr. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 11: SUBSEQUENT EVENTS On May 12, 2020, the Company borrowed an additional $1,000,000 from its existing related party lender (see Note 4). On July 3, 2020, the Company borrowed an additional $500,000 from this same related party. The borrowings bear interest at a rate of 24% per annum and are due on February 8, 2021. On July 8, 2020, the Company entered into a Purchase Order Financing Agreement (“PO Financing Agreement”) whereby $1,900,000 of the total $3,600,000 in outstanding debt due to the related party as of the date of the agreement has been labeled as inventory financing (“PO Financing Amount”). The PO Financing Amount, along with any accrued interest, is due in full no later than six months from the effective date of the PO Financing Agreement, or January 8, 2021. The outstanding balance of the PO Financing Amount bears interest at a rate of 2% per month. The Company has agreed to repay the PO Financing Amount together with any accrued, but unpaid, interest thereon out proceeds from the sale of its products, licensing activities, revenue to be generated from operations and/or amounts received by the Company from investors, lenders, financiers, financing sources or other persons before making payments of any other nature (including dividends and distributions) except for payments required to finance the Company’s operations. On August 10, 2020, the Company borrowed an additional $250,000 subject to the PO Financing Agreement. On May 15, 2020, the Company issued 243,800 shares of its common stock to a vendor as compensation for business advisory services performed. Effective June 1, 2020, the Company and Montsaic entered into an amendment to the $1.7 million convertible note payable (see Note 5) to eliminate the conversion right contained in the original agreement and extend the maturity date to June 1, 2021. On May 6, 2020, the Company issued 1,216,560 shares of its common stock to Montsaic as partial satisfaction of the shares issuable under this note payable agreement. On June 30, 2020, the Company entered into a loan agreement with Montsaic to borrow an additional $120,000. This loan bears interest at an annual rate of 12.6% and is required to be repaid in full, together with all accrued, but unpaid, interest by June 30, 2021.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Apr. 30, 2020
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Accordingly, actual results could differ from those estimates.
Financial Statement Reclassification	Financial Statement Reclassification Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid temporary cash investments with an original maturity of three months or less when purchased, to be cash equivalents.
Inventory	Inventory Inventory is valued at the lower of the cost or net realizable value. The Company’s inventory as of April 30, 2020 consisted of $663,750 of finished goods and $255,894 of component and replacement parts. The Company had no inventory at April 30, 2019.
Concentration of Credit Risk	Concentration of Credit Risk The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash or cash equivalents.
Revenue Recognition	Revenue Recognition Effective May 1, 2018, the Company adopted Accounting Standards Codification (“ASC”) 606, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services. The adoption of ASC 606 had no impact on the Company’s historical financial statements. The Company’s contracts with customers contain one performance obligation. The Company recognizes revenue for its performance obligation at a point in time once products are shipped or physically delivered, depending on the third-party shipping terms. Amounts collected from customers in advance of revenue being recognized are reflected as deferred revenue on the accompanying consolidated balance sheets.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in the absence of a principal, most advantageous market for the specific asset or liability. GAAP provides for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows: ● Level 1 — Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access. ● Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including: – Quoted prices for similar assets or liabilities in active markets – Quoted prices for identical or similar assets or liabilities in markets that are not active – Inputs other than quoted prices that are observable for the asset or liability – Inputs that are derived principally from or corroborated by observable market data by correlation or other means ● Level 3 — Inputs that are unobservable and reflect the Company’s own assumptions about the assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows). The Company’s financial instruments consist of cash and cash equivalents, accounts payable and amounts due to related parties. The carrying amount of these financial instruments approximates fair value due to their short-term maturity. The Company’s derivative liability was calculated using Level 2 assumptions.
Income Taxes	Income Taxes Income taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts expected to be realized, but no less than quarterly.
Property and Equipment	Property and Equipment Property and equipment are recorded at cost and are depreciated on a straight-line basis over their estimated useful lives of three years. At April 30, 2019, the Company had total capitalized property and equipment costs of $3,000 and accumulated depreciation of $2,250. In connection with the Stock Purchase Agreement (see Note 1), the existing property and equipment with a remaining book value of $500 was contributed to the previous majority shareholder of Lazex. As of April 30, 2020, the remaining book value of property and equipment were $0. Depreciation expense for the year ended April 30, 2020 and 2019 was $250 and $1,000, respectively.
Intangible Assets	Intangible Assets Intangible assets consisted of capitalized software costs and are amortized on a straight-line basis over an estimated useful life of three years. At April 30, 2019, the Company had total gross intangible assets of $4,800 and accumulated amortization of $3,066. In connection with the Stock Purchase Agreement (see Note 1), the existing capitalized software with a remaining book value of $1,334 was contributed to the previous majority shareholder of Lazex. As of April 30, 2020, the remaining book value of intangible assets were $0. Amortization expense for the year ended April 30, 2020 and 2019 was $400 and $1,600, respectively.
Long-lived Assets	Long-Lived Assets In accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. Impairment, if any, is based on the excess of the carrying amount over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. There was no impairment of long-lived assets identified during the year ended April 30, 2020 or 2019.
Warrants	Warrants The Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in connection with certain note payable agreements. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants granted in connection with ongoing arrangements are more fully described in Note 6: Note Payable and Note 8: Stockholders’ Deficit. The warrants granted during the year ended April 30, 2020 and 2019 were valued using the Black-Scholes pricing method on the date of grant using the following assumptions below. 2020 2019 Expected life in years 2 - 5 years NA Stock price volatility 121.4% - 144.2% NA Risk free interest rate 0.36% - 2.43% NA Expected dividends 0% NA
Basic and Diluted Earnings Per Share	Basic and Diluted Earnings Per Share Basic earnings per share are calculated by dividing income available to stockholders by the weighted-average number of common shares outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common share equivalents outstanding during the period. The Company had 8,137,859 common shares issuable as of April 30, 2020 (see Note 5) which were not included in the calculation of diluted earnings per share as the effect is antidilutive. The Company also had outstanding notes payable convertible into 7,465,811 shares of common stock as of April 30, 2020 (see Note 5), as well as outstanding warrants exercisable into 13,000,000 shares of common stock which were excluded from calculation of diluted earnings per share as the effect is antidilutive. There were no common share equivalents outstanding during the year ended April 30, 2019. As a result, the basic and diluted earnings per share are the same for each of the periods presented.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In February 2016, the FASB issued Accounting Standards Update 2016-02, “Leases” (Topic 842). This guidance is effective for public entities for fiscal years beginning after December 15, 2018 including the interim periods within those fiscal years. Early application is permitted. Under the new provisions, all lessees will report a right-of-use asset and a liability for the obligation to make payments for all leases with the exception of those leases with a term of 12 months or less. All other leases will fall into one of two categories: (i) Financing leases, similar to capital leases, which will require the recognition of an asset and liability, measured at the present value of the lease payments and (ii) Operating leases which will require the recognition of an asset and liability measured at the present value of the lease payments. The Company has adopted this standard on May 1, 2019 with no significant impact to the Company’s financial statements. Other accounting pronouncements have been issued but deemed by management to be outside the scope of relevance to the Company.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Summary of Warrants Granted Valuation using Black-Scholes Pricing Method (Tables)	12 Months Ended
	Apr. 30, 2020
Accounting Policies [Abstract]
Summary of Warrants Granted Valuation using Black-Scholes Pricing Method	The warrants granted during the year ended April 30, 2020 and 2019 were valued using the Black-Scholes pricing method on the date of grant using the following assumptions below. 2020 2019 Expected life in years 2 - 5 years NA Stock price volatility 121.4% - 144.2% NA Risk free interest rate 0.36% - 2.43% NA Expected dividends 0% NA

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	12 Months Ended
	Apr. 30, 2020
Convertible Notes Payable Tables Abstract
Schedule of Future Maturities of Long-term Convertible Debt	Future scheduled maturities of long-term convertible debt are as follows. Year Ended April 30, 2021 $ 125,000 2022 1,700,000 Total $ 1,825,000

Note Payable (Tables)

Note Payable (Tables)	12 Months Ended
	Apr. 30, 2020
Note Payable Tables Abstract
Scheduled Maturities Of Long-Term Debt	Future scheduled maturities of long-term debt are as follows. Year Ended April 30, 2021 $ - 2022 500,000 Total $ 500,000

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Apr. 30, 2020
Schedule of Net Deferred Tax	Net deferred tax assets from operations in the US, using an effective tax rate of 21%, consisted of the following. April 30, April 30, 2020 2019 Deferred tax assets (liabilities): Loss carryforwards $ 301,000 $ 9,500 Depreciation - (400 ) Related party accruals 79,000 - Start-up costs 61,000 - Valuation allowance (441,000 ) (9,100 ) Net deferred tax assets $ - $ -
Schedule of Income Tax Provision	The income tax provision differs from the amount of income tax determined by applying the applicable US statutory income tax rate of 21% to pretax loss due to the following for the year ended April 30, 2020 and 2019. April 30, April 30, 2020 2019 Income tax benefit based on book loss at US statutory rate $ (1,273,000 ) $ (5,900 ) Stock-based compensation 786,000 - Debt discount amortization 15,000 - Related party accruals 79,000 - Start up costs 61,000 - Interest expense 41,000 - Meals and entertainment 1,000 - Depreciation - 400 Valuation allowance 290,000 5,500 Total income tax provision $ - $ -
ISRAEL
Schedule of Net Deferred Tax	Net deferred tax assets from operations in Israel , using an effective tax rate of 23%, consisted of the following. The net deferred tax assets as of April 30, 2019 represent the amounts from SBL contributed to the Company on May 1, 2019. April 30, April 30, 2020 2019 Deferred tax assets (liabilities): Loss carryforwards $ 384,000 $ 201,000 Accrued expenses 63,000 16,000 Research and development costs 23,000 - Valuation allowance (470,000 ) (216,000 ) Net deferred tax assets $ - $ -
Schedule of Income Tax Provision	The income tax provision differs from the amount of income tax determined by applying the applicable Israeli statutory income tax rate of 23% to pretax loss due to the following for the year ended April 30, 2020. As the net assets of SBL were contributed on May 1, 2019, there is no income tax provision related to the year ended April 30, 2019. April 30, 2020 Income tax benefit based on book loss at Israeli statutory rate $ (728,000 ) Debt discount amortization 430,000 Related party accruals 44,000 Travel 38,000 Research and development 23,000 Other non-deductible items 9,000 Valuation allowance 184,000 Total income tax provision $ -

Organization and Basis of Pre_2

Organization and Basis of Presentation (Details Narrative) - USD ($)	Sep. 16, 2019	Aug. 23, 2019	Apr. 30, 2020	Feb. 25, 2020	Feb. 24, 2020	Feb. 10, 2020	Apr. 30, 2019
Common stock, shares authorized			300,000,000	300,000,000	75,000,000		300,000,000
Stock split, description			four-to-one forward split of the outstanding shares of common stock
Sole Shareholder of SBL [Member]
Ownership percentage	82.00%
Number of shares owned	20,000,000
Slinger Bag Americas Inc [Member]
Ownership percentage	100.00%
Number of shares exchanged	20,000,000
Slinger Bag Ltd [Member]
Ownership percentage						100.00%
Stock Purchase Agreement [Member] | Slinger Bag Americas Inc [Member]
Ownership percentage		100.00%
Number of shares issued for acquisition		20,000,000
Number of shares issued for acquisition, value		$ 332,239

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Apr. 30, 2020	Apr. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ (10,228,513)	$ (33,091)

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Inventory finished goods	$ 663,750
Inventory component and replacement parts	255,894
Inventory	$ 919,644
Property and equipment estimated useful life	3 years
Capitalized cost of property and equipment		3,000
Accumulated amortization of property and equipment		2,250
Property and equipment		750
Depreciation expense	$ 250	1,000
Estimated useful life of intangible asset	3 years
Capitalized software gross		4,800
Accumulated amortization of capitalized software		3,066
Capitalized software, remaining book value	$ 0	1,334
Amortization expense	400	1,600
Impairment of long-lived assets
Antidilutive securities not included in calculation	8,137,859
Common share equivalents outstanding	24,749,354	24,380,000
Warrant [Member]
Antidilutive securities not included in calculation	13,000,000
Notes Payable [Member]
Antidilutive securities not included in calculation	7,465,811
Stock Purchase Agreement [Member]
Property and equipment		$ 500

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Warrants Granted Valuation using Black-Scholes Pricing Method (Details) - Warrant [Member] - Valuation Technique, Option Pricing Model [Member]	12 Months Ended
	Apr. 30, 2020
Measurement Input, Expected Dividend Rate [Member]
Measurement input, rate	0
Minimum [Member] | Measurement Input Expected Term [Member]
Measurement input, term	2 years
Minimum [Member] | Measurement Input, Price Volatility [Member]
Measurement input, rate	1.214
Minimum [Member] | Measurement Input, Risk Free Interest Rate [Member]
Measurement input, rate	0.0036
Maximum [Member] | Measurement Input Expected Term [Member]
Measurement input, term	5 years
Maximum [Member] | Measurement Input, Price Volatility [Member]
Measurement input, rate	1.442
Maximum [Member] | Measurement Input, Risk Free Interest Rate [Member]
Measurement input, rate	0.0243

Note Payable - Related Party (D

Note Payable - Related Party (Details Narrative) - USD ($)

Jul. 08, 2020

May 01, 2020

Mar. 02, 2020

Dec. 13, 2019

Dec. 11, 2019

Jan. 06, 2019

Apr. 30, 2020

Apr. 30, 2019

May 12, 2020

Feb. 08, 2020

Dec. 03, 2019

Oct. 03, 2019

Borrowings

$ 2,100,000

Interest rate

24.00%

Proceeds from related party debt

2,100,000

9,000

Interest expenses related party debt

171,918

Accrued interest - related parties

$ 138,967

Subsequent Event [Member]

Interest rate

20.00%

Loan Agreement [Member] | Former Shareholder [Member]

Borrowings

$ 200,000

$ 700,000

$ 200,000

$ 500,000

$ 500,000

Interest rate

24.00%

24.00%

24.00%

12.00%

12.00%

Debt instrument maturity date

Jan. 8, 2021

Jul. 15, 2020

Jan. 8, 2021

Loan Agreement [Member] | Former Shareholder [Member] | Subsequent Event [Member]

Debt instrument maturity date

Jan. 8, 2021

Proceeds from related party debt

$ 1,750,000

Amended and Restated Loan Agreement [Member]

Debt instrument maturity date

Jul. 15, 2020

Amended and Restated Loan Agreement [Member] | Subsequent Event [Member]

Debt instrument maturity date

Jan. 8, 2021

Amended and Restated Loan Agreement [Member] | Minimum [Member]

Interest rate

12.00%

Amended and Restated Loan Agreement [Member] | Maximum [Member]

Interest rate

24.00%

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative) - USD ($)

Mar. 02, 2020

Feb. 11, 2020

Nov. 20, 2019

Sep. 11, 2019

Jun. 01, 2019

Apr. 30, 2020

Apr. 30, 2019

May 12, 2020

May 06, 2020

Feb. 08, 2020

Sep. 16, 2019

Jan. 01, 2019

Convertible note payable

$ 1,825,000

Debt instrument interest rate

24.00%

Common stock, shares issued

369,354

24,749,354

24,380,000

Shares issuable

8,137,859

Derivative liability

Amortization of debt discount

1,565,174

Unamortized debt discount

206,061

Subsequent Event [Member]

Debt instrument interest rate

20.00%

Common stock, shares issued

1,216,560

Warrant [Member]

Value of warrant

1,492,188

Convertible Note Payable Agreement [Member]

Convertible note payable

$ 125,000

$ 125,000

Debt instrument interest rate

12.00%

Debt instrument maturity date

Nov. 20, 2020

Debt conversion converted instrument, shares

369,354

Debt conversion converted instrument, value

$ 53,571

$ 53,571

$ 566,667

Debt issuance date

Nov. 20, 2019

Feb. 11, 2020

Sep. 11, 2019

Amount of conversion option

$ 358,855

Amortization of debt discount

53,571

Accrued interest

$ 4,274

Reclassification of derivative liability to additional paid-in capital

53,571

Convertible Note Payable Agreement [Member] | Debtholder [Member]

Options for debtholders conversion price percentage

70.00%

Convertible Note Payable Agreement [Member] | Montsaic Investments [Member]

Convertible note payable

$ 1,700,000

Debt instrument interest rate

12.60%

Debt instrument maturity date, description

All outstanding amounts are due on the maturity date 360 days after the loan issue date.

Maximum percentage of payment on oustanding debt

50.00%

Ownership percentage

33.00%

Convertible Note Payable Agreement [Member] | Montsaic Investments [Member] | Debtholder [Member]

Options for debtholders conversion price percentage

70.00%

Warrant Assignment and Conveyance Agreement [Member] | Montsaic Investments [Member]

Ownership percentage

100.00%

33.00%

February 2020 Convertible Note Payable Agreement [Member]

Derivative liability

Amortization of debt discount

10,699

Unamortized debt discount

42,872

Convertible debt discounts

$ 248,933

$ 0

Convertible Notes Payable - Sch

Convertible Notes Payable - Schedule of Furture Maturities of Long-term Convertible Debt (Details) - Convertible Debt [Member]	Apr. 30, 2020USD ($)
2021	$ 125,000
2022	1,700,000
Total	$ 1,825,000

Note Payable (Details Narrative

Note Payable (Details Narrative) - USD ($)	Mar. 16, 2020	Apr. 30, 2020	Feb. 08, 2020	Apr. 30, 2019
Borrowings		$ 2,100,000
Interest rate			24.00%
Discounted allocated from valuation of warrants		393,975
Debt principal outstanding		500,000
Remaining discount amount		$ 106,025
Promissory Note Payable [Memebr]
Borrowings	$ 500,000
Interest rate	12.00%
Debt instrument maturity date	Mar. 16, 2022
Warrants issued	500,000
Warrant exercise price	$ 0.40
Discounted allocated from valuation of warrants	$ 112,990

Notes Payable - Schedule of mat

Notes Payable - Schedule of maturities of long-term debt (Details)	Apr. 30, 2020USD ($)
Total debt	$ 500,000
2021 [Member]
Total debt
2022 [Member]
Total debt	$ 500,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	Apr. 30, 2020	Apr. 30, 2019
Related Party Transactions [Abstract]
Outstanding borrowings	$ 377,106	$ 10,114
Outstanding notes payable	2,100,000
Accrued interest - related parties	$ 138,967

Stockholders' Deficit (Details

Stockholders' Deficit (Details Narrative) - USD ($)	May 16, 2020	Apr. 30, 2020	Mar. 02, 2020	Sep. 16, 2019	May 15, 2018	Jun. 30, 2020	Feb. 25, 2020	Feb. 24, 2020	Sep. 11, 2019	Apr. 30, 2019
Common stock, shares authorized		300,000,000					300,000,000	75,000,000		300,000,000
Common stock, par value		$ 0.001								$ 0.001
Common stock, shares issued		24,749,354	369,354							24,380,000
Common stock, shares outstanding		24,749,354								24,380,000
Shares issuable related to agreement with affiliate						$ 837,313
Shares issuable		8,137,859
Common stock cancelled					240,000
Stock refund payable										$ 1,200
Convertible notes payable		82,128
Accrued interest		138,967
Derivative liability amount		$ 620,238
Derivative liability reclassified as additional paid in capital			$ 53,571
Stock purchase agreement liabilities forgiven						$ 15,289
Stock warrant	$ 112,990
Issuance of common stock under agreement		8,137,859
Warrant issued for employees and officers compensation						12,500,000
Stock-based compensation expense		$ 3,741,746
Warrant Assignment and Conveyance Agreement [Member] | Montsaic Investments [Member]
Ownership percentage				33.00%					100.00%
Warrant amount				$ 1,492,188

Commitments And Contingencies (

Commitments And Contingencies (Details Narrative) - USD ($)	12 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Notes to Financial Statements
Short term lease	$ 2,800	$ 0

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Effective income tax rate, percentage	21.00%	21.00%
Net operating loss carryforwards	$ 1,424,000
Imcome tax, penalties and interest
ISRAEL
Effective income tax rate, percentage	23.00%
Net operating loss carryforwards	$ 1,671,000

Income Taxes - Schedule of Net

Income Taxes - Schedule of Net Deferred Tax (Details) - USD ($)	Apr. 30, 2020	Apr. 30, 2019
Deferred tax assets (liabilities): Loss carryforwards	$ 301,000	$ 9,500
Deferred tax assets (liabilities): Depreciation		(400)
Deferred tax assets (liabilities): Related party accruals	79,000
Deferred tax assets (liabilities): Start-up costs	61,000
Valuation allowance	(441,000)	(9,100)
Net deferred tax assets
ISRAEL
Deferred tax assets (liabilities): Loss carryforwards	384,000	201,000
Deferred tax assets (liabilities): Accrued expenses	63,000	16,000
Deferred tax assets (liabilities): Research and development costs	23,000
Valuation allowance	(470,000)	(216,000)
Net deferred tax assets

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income Tax Provision (Details) - USD ($)	12 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Income tax benefit based on book loss at US statutory rate	$ (1,273,000)	$ (5,900)
Stock-based compensation	786,000
Debt discount amortization	15,000
Related party accruals	79,000
Start up costs	61,000
Interest expense	41,000
Meals and entertainment	1,000
Depreciation		400
Other non-deductible items
Valuation allowance	290,000	5,500
Total income tax provision
ISRAEL
Income tax benefit based on book loss at US statutory rate	(728,000)
Debt discount amortization	430,000
Related party accruals	44,000
Travel	38,000
Research and development	23,000
Other non-deductible items	9,000
Valuation allowance	184,000
Total income tax provision

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Jul. 03, 2020	Jun. 30, 2020	Jun. 02, 2020	May 15, 2020	May 12, 2020	May 06, 2020	Apr. 30, 2020	Mar. 02, 2020	Feb. 08, 2020	Apr. 30, 2019
Common stock, shares issued							24,749,354	369,354		24,380,000
Convertible note payable							$ 1,825,000
Debt instrument interest rate									24.00%
Subsequent Event [Member]
Common stock, shares issued						1,216,560
Debt instrument interest rate					20.00%
Stock based compensation to vendors				$ 243,800
Subsequent Event [Member] | PO Financing Agreement [Member]
Additional Borrowings	$ 500,000				$ 1,000,000
Debt outstanding	$ 3,600,000			$ 250,000	$ 1,900,000
Subsequent Event [Member] | Montsaic [Member]
Common stock, shares issued						1,216,560
Convertible note payable			$ 1,700,000
Debt instrument interest rate		12.60%
Debt instrument maturity date			Jun. 1, 2021
Additional Borrowings